The potencies of edrophonium and neostigmine as antagonists of pancuronium

Dose response curves were constructed for edrophonium and neostigmine when used to antagonise pancuronium, 0.07 mg/kg during thiopentone‐nitrous oxide‐halothane anaesthesia. The antagonist was given when 10% twitch height had been restored and the effect was measured 10 minutes later. Recoveries to 50% and 90% twitch height were achieved with 167 and 828 μg/kg of edrophonium, and 10.5 and 51 μg/kg of neostigmine. The dose response curves were parallel and neostigmine was 16 times more potent than edrophonium. Combinations of equipotent doses of edrophonium and neostigmine were also administered and produced additive but not synergistic effects. It is concluded that either edrophonium or neostigmine may be used for the reversal of pancuronium neuromuscular blockade, but the combination of the two offers no advantage.

[1]  R. Miller,et al.  A new look at an old drug. , 1983, Anesthesiology.

[2]  F. Donati,et al.  Twitch Depression and Train‐of–Four Ratio after Antagonism of Pancuronium with Edrophonium, Neostigmine, or Pyridostigmine , 1983, Anesthesia and analgesia.

[3]  R. Miller,et al.  Edrophonium: Duration of Action and Atropine Requirement in Humans during Halothane Anesthesia , 1982, Anesthesiology.

[4]  W. Kerr,et al.  Some actions of Org NC 45 and of edrophonium in the anaesthetized cat and in man. , 1982, British journal of anaesthesia.

[5]  D. Stanski,et al.  Pharmacokinetics of Edrophonium and Neostigmine When Antagonizing d‐Tubocurarine Neuromuscular Blockade in Man , 1981, Anesthesiology.

[6]  H. H. Ali,et al.  Combination of Pancuronium and Metocurine: Neuromuscular and Hemodynamic Advantages over Pancuronium Alone , 1981, Anesthesia and analgesia.

[7]  W. Bowman.  Prejunctional and Postjunctional Cholinoceptors at the Neuromusclar Junction , 1980, Anesthesia and analgesia.

[8]  D. Bevan,et al.  Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium , 1980, Anesthesiology.

[9]  T. N. Calvey,et al.  Differential effects of myoneural blocking drugs on neuromuscular transmission. , 1980, British journal of anaesthesia.

[10]  R. Cork,et al.  DO LUNG FUNCTION TESTS IMPROVE WITH MASSIVE WEIGHT LOSS , 1980 .

[11]  H. H. Ali,et al.  Potentiation of Neuromuscular Blockade in Man Produced by Combinations of Pancuronium and Metocurine or Pancuronium and d‐Tubocurarine , 1980, Anesthesia and analgesia.

[12]  Aaron F. Kopman.  Edrophonium Antagonism of Pancuronium‐induced Neuromuscular Blockade in Man: A Reappraisal , 1979, Anesthesiology.

[13]  D. Bevan.  Reversal of pancuronium with edrophonium , 1979, Anaesthesia.

[14]  P. Monks,et al.  THE REVERSAL OF NON-DEPOLARISING RELAXANTSA COMPARISON OF TUBOCURARINE, GALLAMINE,AND PANCURONIUM , 1973 .

[15]  R. Miller,et al.  Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine. , 1972, Anesthesiology.

[16]  P. Monks,et al.  The reversal of non–depolarising relaxants , 1972, Anaesthesia.

[17]  H. H. Ali,et al.  Stimulus frequency in the detection of neuromuscular block in humans. , 1970, British journal of anaesthesia.

[18]  R. Katz.  Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in Man , 1967, Anesthesiology.

[19]  R. Kitz.  THE CHEMISTRY OF ANTICHOLINESTERASE ACTIVITY , 1964 .